IFC Holdings’s iShares Biotechnology ETF IBB Stock Holding History

IFC Holdings’s Portfolio IBB Stock Details IBB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q1	–	Sell	-17,859	Closed	-$1.91M	–	181
2017 Q4	$1.91M	Buy	17,859 +2,352	+15%	+$251K	0.13%	111
2017 Q3	$1.72M	Buy	15,507 +5,391	+53%	+$576K	0.12%	124
2017 Q2	$1.05M	Buy	+10,116	New	+$996K	0.08%	178
2016 Q4	–	Sell	-2,094	Closed	-$201K	–	436
2016 Q3	$201K	Buy	+2,094	New	+$199K	0.02%	371
2016 Q2	–	Sell	-2,259	Closed	-$202K	–	403
2016 Q1	$202K	Sell	2,259 -204	-8%	-$18.2K	0.03%	345
2015 Q4	$275K	Sell	2,463 -90	-4%	-$9.77K	0.04%	288
2015 Q3	$266K	Sell	2,553 -147	-5%	-$17.6K	0.04%	291
2015 Q2	$335K	Hold	2,700	–	–	0.05%	267
2015 Q1	$314K	Buy	2,700 +162	+6%	+$17.9K	0.05%	275
2014 Q4	$262K	Buy	+2,538	New	+$247K	0.04%	296

Other funds holding IBB

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return

Natixis Paris, France $24.8B AUM 35.22% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

IFC Holdings's IBB Position: Q1 2018 in Review

IFC Holdings sold out of iShares Biotechnology ETF (IBB) in Q1 2018, closing a stake of 17,859 shares — an estimated $1.91M sold.

IFC Holdings first reported a position in IBB in Q4 2014 and held it in 10 quarters. The position peaked at $1.91M in Q4 2017. 608 funds tracked by Wall St. Rank hold IBB as of Q1 2018.

IFC Holdings reported no remaining iShares Biotechnology ETF position as of Q1 2018 after selling out during the quarter.
IFC Holdings sold 17,859 iShares Biotechnology ETF shares in Q1 2018, an estimated $1.91M.
IFC Holdings first reported a position in iShares Biotechnology ETF in Q4 2014 and held it in 10 quarters.
IFC Holdings's iShares Biotechnology ETF position peaked at $1.91M in Q4 2017.
608 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q1 2018.

Based on IFC Holdings's 13F filing for Q1 2018.